Mcl-1 inhibitors

Mcl-1 inhibitors are drugs designed to block a protein called Mcl-1, which helps some cancer cells survive by preventing cell death. By inhibiting Mcl-1, these drugs aim to restore the natural process of cell death, making cancer cells more likely to die and reducing tumor growth. They are being researched primarily for treating cancers like leukemia and lymphoma, where Mcl-1 plays a key role in helping cancer cells evade destruction. These inhibitors represent a targeted approach to cancer therapy, focusing on disabling specific survival mechanisms of cancer cells to improve treatment outcomes.